TB

TruAlt Bioenergy Ltd

Q4 FY26Agricultural Food & other Products

TruAlt Bioenergy Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹446
Market cap₹4.0K Cr
P/E25.3
Updated23 Aug 2026
Read5 min read

The short version

TruAlt Bioenergy aims to achieve a minimum of 40 crore litres ethanol sales volume, with a bonus target of 55 crore litres (Page 23). TruAlt Bioenergy aims to achieve at least 40 crore litres ethanol sales volume by FY27, with a bonus target of 55 crore litres, reflecting strong volume growth potential.

From TruAlt Bioenergy Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • TruAlt Bioenergy aims to achieve a minimum of 40 crore litres ethanol sales volume, with a bonus target of 55 crore litres (Page 23).
  • Current ethanol sales run rate is 2.2 crore litres/month; expected increase to about 5 crore litres/month once additional 15 crore litres supply from OMCs is implemented (Page 5).
  • Revenue run rate target from ethanol is around INR 350-400 crores per month if 6 crore litres capacity is utilized (Page 27).
  • Execution of 15 crore litres additional ethanol order is pending government/OMC approval, expected after 24-30 months (FY29) (Page 29).
  • Exploration of export opportunities and sustainable aviation fuel plans to diversify revenue streams and improve capacity utilization (Pages 5, 23, 29).

2 more points management made on revenue & sales performance

Profitability & Margins

See what TruAlt Bioenergy Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • TruAlt Bioenergy plans to commission a new plant expected within 24 to 30 months (FY29) for which they will receive a one-shot payment once operational.
  • They are investing in multiple CBG (Compressed Bio-Gas) plants: 9-10 to be live by current year and 10-15 more planned, funded via a 70:30 debt-to-equity mix.
  • Funding includes 51% investment from TruAlt and 49% from JV partners Sumitomo and GAIL, with NABARD loans at favorable interest rates (around 8.65%).
  • A fourth CBG plant is planned pending land clearance, aiming for a total of 11 units.

2 more points management made on capital expenditure plans

Top-ranked in Agricultural Food & other Products

Ranked on what management guided this quarter

5x potential
Rev 1Mar 2
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 2
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what TruAlt Bioenergy Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • TruAlt Bioenergy has existing purchase orders (POs) from private OMCs for about 8 crore litres of ethanol, with only 1.6 crore litres supplied so far; balance 6+ crore litres pending lifting due to delay in indent issuance.
  • A court order dated February 4, 2026, mandates OMCs to lift an additional 15 crore litres within three months; this has not been implemented yet due to ongoing litigation involving LTOA holders and OMCs.
  • Total expected orderbook for FY 2027 including OMC allocations is approximately 40 crore litres (public + private OMCs) plus pending 15 crore litres from the court order, targeting a peak capacity of around 55 crore litres.

2 more points management made on order book & pipeline

TruAlt Bioenergy Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹596 Cr, net profit ₹61 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Agricultural Food & other Products this season

  • Uttam Sugar Mills Ltd (Q4 FY26)

    Consolidated: ₹471.87 Cr (Q4 FY26) vs ₹569.13 Cr (Q4 FY25), ↓ ~17.1% YoY . Key concall takeaways from Uttam Sugar Mills Ltd's Q4 FY26 earnings call — and how…

  • GRM Overseas Ltd (Q4 FY26)

    597.2 Crores vs. Key concall takeaways from GRM Overseas Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

  • Amir Chand Jagdish Kumar (Exports) Ltd (Q4 FY26)

    694.7 Cr . Key concall takeaways from Amir Chand Jagdish Kumar (Exports) Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

  • Sanstar Ltd (Q4 FY26)

    2,168 million, down 4.2% YoY (compared to Rs. Key concall takeaways from Sanstar Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were TruAlt Bioenergy Ltd Q4 FY26 results?

TruAlt Bioenergy aims to achieve a minimum of 40 crore litres ethanol sales volume, with a bonus target of 55 crore litres (Page 23). TruAlt Bioenergy aims to achieve at least 40 crore litres ethanol sales volume by FY27, with a bonus target of 55 crore litres, reflecting strong volume growth potential.

What is TruAlt Bioenergy Ltd share price analysis?

TruAlt Bioenergy Ltd currently shows a neutral. The stock trades at a P/E of 25.3 with a market cap of ₹3,958 Cr. Investors should review the full earnings analysis for detailed insights.

Is TruAlt Bioenergy Ltd planning capital expenditure?

TruAlt Bioenergy plans to commission a new plant expected within 24 to 30 months (FY29) for which they will receive a one-shot payment once operational.

Keep TruAlt Bioenergy Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.